No records
|
461 |
55213290600 |
Tri Kurniawati |
|
Stem Cells and Tissue Engineering Cluster IMERI |
|
Allogeneic umbilical cord-derived mesenchymal stem cells for treating critical-sized bone defects: a translational study |
Dilogo I.H., Rahmatika D., Pawitan J.A., Liem I.K., Kurniawati T., Kispa T., Mujadid F. |
European Journal of Orthopaedic Surgery and Traumatology |
1 |
Q1 |
|
|
524 |
55213290600 |
Tri Kurniawati |
|
Stem Cells and Tissue Engineering Cluster IMERI |
|
Integration of Umbilical Cord Mesenchymal Stem Cell Application in Hydroxyapatite-Based Scaffolds in the Treatment of Vertebral Bone Defect due to Spondylitis Tuberculosis: A Translational Study |
Rahyussalim A.J., Nugroho A., Zufar M.L.L., Fathurrahman I., Kurniawati T. |
Stem Cells International |
|
Q2 |
|
|
553 |
55213290600 |
Tri Kurniawati |
|
Stem Cells and Tissue Engineering Cluster IMERI |
|
The effect of mesenchymal stem cell-enriched scaffolds on mmp-8 and tgf-? levels of vertebrae postlaminoplasty in rabbit model |
Rahyussalim A.J., Sahputra R.E., Yanwirasti, Manjas M., Whulanza Y., Kurniawati T., Aprilya D., Zufar M.L.L. |
Stem Cells and Cloning: Advances and Applications |
|
Q2 |
|
|
652 |
55213290600 |
Tri Kurniawati |
|
Stem Cells and Tissue Engineering Cluster IMERI |
|
Synthesis, Structural Characterization, Degradation Rate, and Biocompatibility of Magnesium-Carbonate Apatite (Mg-Co3Ap) Composite and Its Potential as Biodegradable Orthopaedic Implant Base Material |
Rahyussalim A.J., Marsetio A.F., Kamal A.F., Supriadi S., Setyadi I., Pribadi P.M., Mubarok W., Kurniawati T. |
Journal of Nanomaterials |
|
Q2 |
|
|
No records
|
588 |
55221773800 |
Fariz Nurwidya |
dr. Fariz Nurwidya, Ph.D. |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Gizi (S3) |
Hyperinflammation syndrome in covid-19 disease: Pathogenesis and potential immunomodulatory agents [Covid-19 hastal???nda hiperenflamasyon sendromu: Patogenez ve potansiyel imm?nomod?latuvar ajanlar] |
Hidayat M., Handayani D., Nurwidya F., Andarini S.L. |
Turkish Journal of Immunology |
|
Q4 |
|
|
700 |
55221773800 |
Fariz Nurwidya |
dr. Fariz Nurwidya, Ph.D. |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Gizi (S3) |
Diagnostic predictors of active tuberculosis infection in diabetic patients with latent tuberculosis: A review on cathelicidin and 1,25-dihydroxyvitamin d3 |
Arliny Y., Yunus F., Burhan E., Andarini S., Jusman S.W.A., Yunir E., Kekalih A., Soeroton A.Y., Nurwidya F. |
Journal of Natural Science, Biology and Medicine |
|
Q3 |
|
|
No records
|
30 |
55240204000 |
Riwanti Estiasari |
Dr. dr. Riwanti Estiasari, Sp.S. |
Departemen Neurologi |
Neurologi (Sp-1) |
Intractable singultus as an initial symptom of medulla oblongata tuberculoma: A rare case report |
Yolanda S., Maharani K., Imran D., Estiasari R. |
Clinical Neurology and Neurosurgery |
|
Q2 |
|
|
266 |
55240204000 |
Riwanti Estiasari |
Dr. dr. Riwanti Estiasari, Sp.S. |
Departemen Neurologi |
Neurologi (Sp-1) |
Improving host-directed therapy for tuberculous meningitis by linking clinical and multi-omics data |
van Crevel R., Avila-Pacheco J., Thuong N.T.T., Ganiem A.R., Imran D., Hamers R.L., Alisjahbana B., Dian S., Estiasari R., Tram T.T.B., Vinh D.N., Hai H.T., Donovan J., Ardiansyah E., Koeken V., Kumar V., Netea M.G., van Laarhoven A., Clish C., Thwaites G., The ULTIMATE consortium |
Tuberculosis |
|
Q2 |
|
|
282 |
55240204000 |
Riwanti Estiasari |
Dr. dr. Riwanti Estiasari, Sp.S. |
Departemen Neurologi |
Neurologi (Sp-1) |
Understanding the effects of CMV on ?? T-cell populations in HIV patients starting antiretroviral therapy |
Ariyanto I.A., Lee S., Estiasari R., Edmands J., Bela B., Soebandrio A., Price P. |
Clinical Immunology |
|
Q2 |
|
|
488 |
55240204000 |
Riwanti Estiasari |
Dr. dr. Riwanti Estiasari, Sp.S. |
Departemen Neurologi |
Neurologi (Sp-1) |
Effect of atorvastatin on subclinical atherosclerosis in virallysuppressed HIV-infected patients with CMV seropositivity: a randomized double-blind placebo-controlled trial |
Yunihastuti E., Rusdi L., Azizi M.S., Estiasari R., Jasirwan C.O.M., Wulandari E.A.T., Purnamasari D., Noviar M.S., Nasution S.A. |
F1000Research |
|
Q1 |
|
|